T1	Participants 60 75	Prostate Cancer
T2	Participants 482 534	a total of 56,294 men aged 55-74 years were screened
T3	Participants 578 628	in five countries of the European Randomised Study
T4	Participants 747 789	Prostate cancer incidence among 92,142 men
T5	Participants 747 858	Prostate cancer incidence among 92,142 men randomly allocated to the control arm of the trial was also assessed
